Related Experiment Video
Updated: Jun 17, 2026

06:04
Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate (HoLEP).
Published on: March 6, 2018
Experience of long-term afala treatment in benign prostatic hyperplasia
1Siberian State Medical University, Federal Agency for Health Care and Social Development, Tomsk.
Bulletin of Experimental Biology and Medicine
|December 23, 2009
Abstract:
The use of ultralow doses of antibodies to prostate-specific antigen (afala) for long-term treatment of benign prostatic hyperplasia in patients with moderate symptoms rapidly and effectively reduces irritative and obstructive symptoms, significantly decreases residual urine volume, and increases the rate of urination. Afala therapy is indicated for patients with stage I-II benign prostatic hyperplasia of moderately pronounced symptoms.
